ArticleJournal of advanced research2026

Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer.

Jie Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.